The hospital infection therapeutics market is a crucial frontier in combating healthcare-associated infections (HAIs). Sourcing from a multitude of resources, including primary research and in-depth interviews, we've delved into the changing landscape of this market and the forces that drive its transformation.
The hospital infection therapeutics market is expected to surge from USD 12.4 billion in…
OpGen, a precision medicine company specializing in molecular diagnostics and informatics to combat infectious diseases, has announced a major feature upgrade for its subsidiary Ares Genetics' AREScloud platform. The upgrade aims to enhance genomic surveillance in healthcare settings by utilizing prospective whole genome sequencing (WGS) of pathogen isolates to identify hospital-associated infections (HAIs) in real-time…